Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Histiocytosis; Histiocytosis, Langerhans-Cell Phase 2 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1 ClinicalTrials
Multiple Myeloma; Neoplasms, Plasma Cell Phase 1 ClinicalTrials
CONTENTS